Prognosis of chronic spontaneous urticaria with an inadequate response to omalizumab. Watanabe H, Takahagi S, Hayama K, Fukunaga A, et al. Int J Dermatol 2025;64:349-358.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Watanabe H, Takahagi S, Hayama K, Fukunaga A, et al. Prognosis of chronic spontaneous urticaria with an inadequate response to omalizumab. Int J Dermatol 2025;64:349-358.
PMID: 39489861